Hidden potential of mass spectrometry over immunoassay solutions

Immunoassay has been the gold standard biomolecule assay for the past fifty years, but those fifty years have highlighted both the benefits and limitations of the immunoassay. LC-MS represents a complementary and potentially future replacement of the immunoassay by offering greater specificity, speed, analyte range, throughput and multiplexing capabilities coupled with a lower cost per sample and reduced sample volumes. Explore the resources below to learn more.


Spotlights

White paper

Can LC-MS ever replace immunoassay?

Expert opinion

Current Trends and Challenges in Clinical Research

Video

New Tools to Combat the Growing Opioid Epidemic


Stay connected

Thermo Fisher Scientific is a leader in the life sciences industry. We are committed to providing pioneering systems-wide mass spectrometry solutions to laboratories worldwide to address the challenges in clinical research. We’re happy to discuss solutions that can put great science into your hands. Make a selection below and let’s get started!

Join our clinical community           Speak with an expert on clinical solutions now

Resources

Support